Welcome: Guest

log in

Bioseeker

BioSeeker Group is an independent, privately owned company based in Sweden since 1999. They focus on business, competitive intelligence in oncology and operate in two business areas: consulting and publishing. BioSeekers Group's mission is to excel our customer's business operations by objective and unbiased research and analysis.

Title Date Price
Cancer Antibodies: Competitive Positioning for Success
Jun 2008 £1,555
Cancer Vaccines: Aim and Shoot
May 2008 £1,555
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
Apr 2008 £1,790
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology
Nov 2007 £2,930
Decoding Big Pharma's R&D Strategy in Oncology
Sep 2007 £1,950
Decoding Big Pharmas R&D Strategy in Oncology
Sep 2007 £2,930
Melanoma - Targeted Therapeutics
Jul 2007 £1,555
Analytical Tool - Targeted Therapeutics: Melanoma
Jul 2007 £2,470
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Melanoma and NSCLC
Jul 2007 £4,125
Antibody Drug Target Atlas in Oncology
Jun 2007 £2,730
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Leukemias and Lymphomas
Jun 2007 £4,125
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer
Jun 2007 £4,125
Analytical Tool - Prostate Cancer
A Therapeutic & Competitive Insight
May 2007 £2,470
Cancer Vaccines
Drug Pipeline Update 2007
May 2007 £1,195
Prostate Cancer
Drug Pipeline Update 2007
May 2007 £1,195
Leukemia Drug Pipeline Update 2007
May 2007 £1,195
Apoptosis in Oncology
Drug Pipeline Update 2007
May 2007 £1,195
Hematological Cancers Drug Pipeline Update 2007
May 2007 £1,590
Analytical Tool - Leukemia Therapeutics & Competitive Insights
May 2007 £2,470
Angiogenesis in Oncology
Drug Pipeline Update 2007
May 2007 £1,195